SBIR/STTR Research Award

IN SITU OPTICAL ANALYZER FOR COMPONENTS IN BIOREACTORS

Award identifier 6f49bd484380830fe0b594a69ad4ef3e97bcf11cc577568abe690a20f689b396Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$102,964

Program and phase

SBIR · Phase I

Award year

2002

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Polestar Technologies, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
CW9GKK95L7Y8
Solicitation number
Not reported
Topic code
Not reported

Research abstract

An optically based instrument for in-situ analysis of multiple chemical components in bioreactors will be developed and applied to monitor key components in hybridoma cell fermentation processed used for producing monoclonal antibodies. Monoclonal antibodies have become valuable agents for new cancer therapy and diagnostic methods.. The in situ analyzer employs a novel design integrating recent advances in opto- electronic technology to provide a multiple component analyzer which eliminates interference from biofouling of exposed optical surfaces. The in situ probe design for multiple component analyzer will be compatible with steam sterilization. In the Phase I program, the cell density monitor will be calibrated and evaluated in a research bioreactor to simultaneously monitor one nutrient and one product compound in a hybridoma fermentation process. The in situ analyzer will find commercial applications in monitoring nutrients, products and undesirable byproducts for improved process control and productivity in industrial bioreactors used for production of monoclonal antibodies as well as other bio-pharmaceuticals. PROPOSED COMMERCIAL APPLICATIONS: Applications of the in-situ monitor would be monitoring of nutrients, products and byproducts in industrial bioreactors used for production of monoclonal antibodies, other biopharmaceuticals and commodity. This would include production, pilot and research scale bioreactors.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

54 SBIR/STTR records share this UEI (1994–2018). Reported award amounts total $17,557,837. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Defense, Department of Health and Human Services, National Aeronautics and Space Administration, Department of Commerce, Department of Energy, National Science Foundation

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.